The NEPI antidiabetes study (NANSY). 1: Short-term dose-effect relations of glimepiride in subjects with impaired fasting glucose

Diabetes, Obesity and Metabolism

Volumn 3, Issue 6, 2001, Pages 443-451

  Lindblad, U ^a,b,c   Lindwall, K ^c   Sjostrand A ^d   Ranstam, J ^c,e   Melander, A ^b,c  

^a Skaraborgs Institutet   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c Network for Pharmacoepidemiology Foundation   (Sweden)

^d Community Care Centre ^*  (Sweden)

^e MALMÖ UNIVERSITY   (Sweden)

Author keywords

Glimepiride; Impaired fasting glucose; Prevention; Type 2 diabetes

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLIMEPIRIDE; GLUCOSE; INSULIN; PLACEBO; SULFONYLUREA; SULFONYLUREA RECEPTOR;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; REBOUND; SHORT COURSE THERAPY;

EID: 0035663656     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2001.00166.x     Document Type: Article

References (26)

1. Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and the risk of complications in patients with type 2 diabetes (UKPDS 33)
2. Impaired glucose tolerant subjects exhibit a beta-cell defect despite normal fasting glycemia
3. Insulin secretory defects in prediabetes
4. Ten-year follow-up of subjects with impaired glucose tolerance: Prevention of diabetes by tolbutamide and diet regulation
5. Glucose tolerance and mortality, including a substudy of tolbutamid treatment
6. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II: Mortality results
7. The ten-year follow-up of the Bedford survey (1962-1972): Glucose tolerance and diabetes
8. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus
9. Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans
10. Cardiovascular effects of conventional sulphonylureas and glimepiride
11. Accurate and precise isotope dilution mass spectrometry method for determining glucose in whole blood
12. A new device for measuring blood pressure in adults
13. Comparison between the Bayer ELITE glucometer and the hexokinase method for glucose determination on the Eppendorf EPOS 5060 using capillary whole blood samples
14. Analytical characterization of electrochemical biosensor test strips for measurement of glucose in low-volume interstitial fluid samples
15. Enzyme immunoassay for intact human insulin in serum or plasma
16. Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies
17. Selective unresponsiveness of pancreatic B cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM
18. Impaired effect of sulphonylurea following increased dosage
19. Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans
20. Mixed meal tolerance test and reactive hypoglycemia
21. Hypoglycaemic counter-regulation in normal and diabetic man
22. Dose linearity assessment of glimepiride (Amaryl®) tablets in healthy volunteers
23. Stimulated insulin production rate following IV glimepiride (HOE 490) in healthy man
24. The Glimepiride Protocol #201 Study Group: A dose-response study of glimepiride in patients with NIDDM who have previously received sulphonylurea agents
25. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38)
26. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39)